Yang et al. developed a liquid biopsy technique that simultaneously detected CA19-9 and Kirsten rat sarcoma viral oncogene homolog mutations, achieving a diagnostic accuracy of 92% for pancreatic ductal adenocarcinoma—substantially outperforming single-marker assays [57]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.